Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Dr. Mark J. LittonPresident, CEO & Director | 17,10k | 0,00 | Derivative Exercise and Retained Stock | - | 59,89k | 39,95% |
| 2026-03-03 | Dr. Mark J. LittonPresident, CEO & Director | -5,16k | 27,69k | Derivative Exercise and Sale | 5,37 | 59,89k | - |
| 2026-03-03 | Mr. Robert RenningerCFO | 2,99k | 0,00 | Derivative Exercise and Retained Stock | - | 15,85k | 23,29% |
| 2026-03-03 | Mr. Robert RenningerCFO | -906,00 | 4,87k | Derivative Exercise and Sale | 5,37 | 15,85k | - |
| 2026-03-03 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 4,40k | 0,00 | Derivative Exercise and Retained Stock | - | 18,38k | 31,46% |
| 2026-03-03 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -1,33k | 7,13k | Derivative Exercise and Sale | 5,37 | 18,38k | - |
| 2026-03-03 | Dr. Kevin ChurchChief Scientific Officer | 4,50k | 0,00 | Derivative Exercise and Retained Stock | - | 25,18k | 21,74% |
| 2026-03-03 | Dr. Kevin ChurchChief Scientific Officer | -1,36k | 7,30k | Derivative Exercise and Sale | 5,37 | 25,18k | - |
| 2026-03-03 | Dr. Javier San MartinChief Medical Officer | 5,70k | 0,00 | Derivative Exercise and Retained Stock | - | 15,89k | 55,92% |
| 2026-03-03 | Dr. Javier San MartinChief Medical Officer | -1,72k | 9,24k | Derivative Exercise and Sale | 5,37 | 15,89k | - |
| 2025-12-31 | Dr. Javier San MartinChief Medical Officer | 3,02k | 0,00 | Derivative Exercise and Retained Stock | - | 10,19k | 42,19% |
| 2025-12-31 | Dr. Javier San MartinChief Medical Officer | -1,64k | 11,31k | Derivative Exercise and Sale | 6,88 | 10,19k | - |
| 2025-12-31 | Dr. Mark J. LittonPresident, CEO & Director | 8,25k | 0,00 | Derivative Exercise and Retained Stock | - | 42,80k | 23,87% |
| 2025-12-31 | Dr. Mark J. LittonPresident, CEO & Director | -2,59k | 17,79k | Derivative Exercise and Sale | 6,88 | 42,80k | - |
| 2025-12-31 | Mr. Robert RenningerCFO | 939,00 | 0,00 | Derivative Exercise and Retained Stock | - | 12,86k | 7,88% |
| 2025-12-31 | Mr. Robert RenningerCFO | -297,00 | 2,04k | Derivative Exercise and Sale | 6,88 | 12,86k | - |
| 2025-12-31 | Dr. Kevin ChurchChief Scientific Officer | 2,79k | 0,00 | Derivative Exercise and Retained Stock | - | 20,68k | 15,60% |
| 2025-12-31 | Dr. Kevin ChurchChief Scientific Officer | -876,00 | 6,03k | Derivative Exercise and Sale | 6,88 | 20,68k | - |
| 2025-12-31 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 2,79k | 0,00 | Derivative Exercise and Retained Stock | - | 13,98k | 24,95% |
| 2025-12-31 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -876,00 | 6,03k | Derivative Exercise and Sale | 6,88 | 13,98k | - |
| 2025-12-18 | Perceptive Advisors LLCUnternehmen | 1,32M | 8,38M | Kauf | 6,35 | 1,86M | 244,13% |
| 2025-06-30 | Dr. Kevin ChurchChief Scientific Officer | 2,81k | 0,00 | Derivative Exercise and Retained Stock | - | 16,89k | 19,99% |
| 2025-06-30 | Dr. Kevin ChurchChief Scientific Officer | -852,60 | 2,50k | Derivative Exercise and Sale | 2,94 | 16,89k | - |
| 2025-06-30 | Dr. Mark J. LittonPresident, CEO & Director | 8,32k | 0,00 | Derivative Exercise and Retained Stock | - | 34,55k | 31,73% |
| 2025-06-30 | Dr. Mark J. LittonPresident, CEO & Director | -2,51k | 7,37k | Derivative Exercise and Sale | 2,94 | 34,55k | - |
| 2025-06-30 | Dr. Javier San MartinChief Medical Officer | 3,58k | 0,00 | Derivative Exercise and Retained Stock | - | 7,17k | 99,94% |
| 2025-06-30 | Dr. Javier San MartinChief Medical Officer | -1,08k | 3,18k | Derivative Exercise and Sale | 2,94 | 7,17k | - |
| 2025-06-30 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 2,81k | 0,00 | Derivative Exercise and Retained Stock | - | 11,19k | 33,60% |
| 2025-06-30 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -852,60 | 2,50k | Derivative Exercise and Sale | 2,94 | 11,19k | - |
| 2025-06-30 | Mr. Robert RenningerCFO | 946,20 | 0,00 | Derivative Exercise and Retained Stock | - | 10,92k | 9,49% |
| 2025-06-30 | Mr. Robert RenningerCFO | -289,70 | 850,27 | Derivative Exercise and Sale | 2,94 | 10,92k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
